Full Prescribing Information - NERLYNX
FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE NERLYNX is indicated for the extended adjuvant treatment of adult patients with early stage
Download Full Prescribing Information - NERLYNX
Information
Domain:
Source:
Link to this page:
Documents from same domain
DOSING AND ADMINISTRATION GUIDE - nerlynx.com
nerlynx.comDOSING AND ADMINISTRATION GUIDE NERLYNX is a kinase inhibitor indicated for the extended adjuvant treatment of adult patients with early-stage HER2-overexpressed/amplified breast cancer, to follow adjuvant trastuzumab-based therapy1 Select IMPORTANT SAFETY INFORMATION
Related documents
easyJet plc Results for the year ending 30 …
corporate.easyjet.comeasyJet plc Results for the year ending 30 September 2017 easyJet delivers robust performance, demonstrating strong cost control with enhanced
Financial Accounting (F3/FFA) September 2017 to …
www.accaglobal.com© ACCA 2017-18 All rights reserved. 1 Financial Accounting (F3/FFA) September 2017 to August 2018 This syllabus and study guide are designed to help with teaching and learning and is intended to
INTERIM RESULTS PRESENTATION - Amerisur …
www.amerisurresources.com1 INTERIM RESULTS PRESENTATION 25 SEPTEMBER 2017 JOHN WARDLE NICK HARRISON A Latin American Producer & Explorer www.amerisurresources.com
INVESTOR PRESENTATION Q3 2017 RESULTS - …
www.asm.comOctober 31, 2017 | ASM proprietary information | 3 INVESTMENT HIGHLIGHTS › ALD is a key growth market ALD market expected to grow by double digits from ’15 to ’20-’21